Teaching hospital Program year 2025 Source: CMS Open Payments

UCI Medical Center

CA

CCN 050348 CMS hospital 15742

Open in the dashboard

General payments

$15,476,527

2,012 payments

Research payments

$128,974,373

8,838 payments

Through program year 2025, UCI Medical Center is reported as receiving $15,476,527 in general payments and $128,974,373 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $2,404,928 266
2025 Research $20,642,307 1,297
2024 General $2,747,806 279
2024 Research $22,794,585 1,538
2023 General $2,691,494 280
2023 Research $19,713,846 1,268
2022 General $1,566,581 283
2022 Research $15,684,183 1,036
2021 General $1,851,110 231
2021 Research $18,953,118 1,104
2020 General $1,396,528 197
2020 Research $18,008,815 1,247
2019 General $2,818,080 476
2019 Research $13,177,519 1,348

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $1,080,963 77 payments
  2. Genzyme Corporation $1,009,228 40 payments
  3. KARL STORZ Endoscopy-America $874,666 431 payments
  4. Intuitive Surgical, Inc. $841,190 50 payments
  5. Cook Incorporated $747,948 42 payments
  6. Olympus Corporation of the Americas $723,430 33 payments
  7. Alcon Research LLC $625,885 11 payments
  8. Medical Device Business Services, Inc. $625,630 46 payments
  9. Pfizer Inc. $502,610 38 payments
  10. AbbVie, Inc. $429,400 39 payments
  11. Other $8,015,578 1,205 payments
What the payments were for General payments · program years 2019–2025
  1. Grant $7,769,066 420 payments
  2. Space rental or facility fees (teaching hospital only) $3,049,234 714 payments
  3. Education $1,825,979 481 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,277,095 120 payments
  5. Long term medical supply or device loan $663,226 49 payments
  6. Charitable Contribution $239,012 73 payments
  7. Consulting Fee $235,486 14 payments
  8. Royalty or License $210,072 9 payments
  9. Gift $144,012 105 payments
  10. Debt forgiveness $33,026 22 payments
  11. Other $30,319 5 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $707,697 23 payments
  2. RS 4i Plus Sequential Stimulator $303,108 2 payments
  3. No Product Discussed $254,060 5 payments
  4. Disposable Biopsy Forceps $221,361 3 payments
  5. General Non-Equipment $193,044 6 payments
  6. Tele Pack X Led,Ccu/Light Source/Monitor $174,662 33 payments
  7. NanoKnife $167,833 3 payments
  8. Single Use Electrosurgical Hemostatic Forceps $158,856 10 payments
  9. Titan $155,770 5 payments
  10. EchoTip $146,960 34 payments
  11. Other $9,050,703 1,465 payments

A payment can name more than one product, so these amounts overlap.

2,012 general · 8,838 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record